Publications by authors named "Mathurin Fumery"

Claim this Profile
D
Diagnosis and management of patients with Crohn's disease. Position paper from the GETAID.
Aurélien Amiot, Anthony Buisson, Jean Marc Gornet, Mathurin Fumery, Lucine Vuitton

Clin Res Hepatol Gastroenterol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intestinal Ultrasound Transmural Healing Was Associated With Improved Long-Term Outcomes Among Patients With Endoscopic Remission: Results of a Prospective Study.
Clara Yzet, Amélie Plancke, Franck Brazier, Lucien Grados, Elise Derval, Mathurin Fumery

Aliment Pharmacol Ther· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-Term Outcome of Colonic and Ileal Crohn's Disease: A Two-Decade Population-Based Study in Pediatric-Onset Disease.
Mathurin Fumery, Guillaume Savoye, Hélène Sarter, Claire Dupont-Lucas, Valérie Bertrand

Inflamm Bowel Dis· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognosis of pediatric-onset inflammatory bowel disease associated with primary sclerosing cholangitis: A population-based study.
Marie-Laura Godet, Hélène Sarter, Frédéric Gottrand, Colin Saoudi, Alexandre Louvet, Mathurin Fumery

J Pediatr Gastroenterol Nutr· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of histological healing on ulcerative colitis disease course among patients with endoscopic healing: results of a prospective study.
Clara Yzet, Camille Robert, Franck Brazier, Erica Meudjo, Capucine Moreau, Mathurin Fumery

Clin Res Hepatol Gastroenterol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-world comparison of effectiveness between ustekinumab and a second-line anti-TNF agent in patients with symptomatic stricturing Crohn's disease failing to respond to a first-line anti-TNF agent: the USTEKNOSIS study.
Guillaume Le Cosquer, Bruno Pereira, Arthur Jammet, Mathurin Fumery, Anthony Buisson

Therap Adv Gastroenterol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term Disease Course of Crohn's Disease in a Prospective European Population-based Inception Cohort: An Epi-IBD Cohort Study.
Mads Damsgaard Wewer, Søren Lophaven, Peter L Lakatos, Lorant Gonczi, Riina Salupere, Mathurin Fumery

Clin Gastroenterol Hepatol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Expert opinion on hot topics in the field of IBD.
Lucine Vuitton, Marianne Hupé, Lucien Grados, Aurélien Amiot, Laurent Peyrin-Biroulet, Mathurin Fumery

Clin Res Hepatol Gastroenterol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rectal and Rectosigmoid Endoscopy to Assess Endoscopic and Histological Remission in Ulcerative Colitis: A Prospective Study.
Clara Yzet, Capucine Moreau, Denis Chatelain, Erica Meudjo, Franck Brazier, Mathurin Fumery

Inflamm Bowel Dis· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The CROCO (CROhn's Disease COhort Study) - study design and protocol.
Joana Revés, Anthony Buisson, Johan Burisch, Naila Arebi, Ryan Ungaro, Mathurin Fumery

Therap Adv Gastroenterol· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Blood proteomic signatures associated with disease activity in inflammatory bowel diseases.
Maëva Veyssière, Nassim Hammoudi, Lionel Le Bourhis, Déborah Hassid, Joëlle Bonnet, Mathurin Fumery

J Crohns Colitis· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Subcutaneous vedolizumab dose intensification in inflammatory bowel disease patients: the OPTI-VEDO multicenter study from the GETAID.
Pauline Wils, Romain Altwegg, Anthony Buisson, Lucine Vuitton, Stephane Nancey, Mathurin Fumery

J Crohns Colitis· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characterization of biomechanical risk factors during endoscopic submucosal dissection: Ergonomic pilot study.
Clara Yzet, Léa Leroy, Sylvain Chamot, Mathieu Pioche, Franck Brazier, Mathurin Fumery

Endosc Int Open· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
International consensus on the use of intestinal ultrasound in inflammatory bowel disease trials.
Mariangela Allocca, Vipul Jairath, Bruce E Sands, David T Rubin, Bénédicte Caron, Mathurin Fumery

J Crohns Colitis· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment sequencing in inflammatory bowel disease: Towards clinical precision medicine.
Léa Sequier, Bénédicte Caron, Sailish Honap, Ludovic Caillo, Romain Altwegg, Mathurin Fumery

Best Pract Res Clin Gastroenterol· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effectiveness of Switching From Intravenous to Subcutaneous Infliximab in Patients With Inflammatory Bowel Disease: An individual participant data meta-analysis.
Fraser Cummings, Philip J Smith, Mathurin Fumery, Sohail Rahmany, Sreedhar Subramanian

J Clin Gastroenterol· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-world Comparison of the Effectiveness of Tofacitinib and Ustekinumab in Patients With Ulcerative Colitis: The TORUS Study.
Anthony Buisson, Mélanie Serrero, Romain Altwegg, Thomas Guilmoteau, Guillaume Bouguen, Mathurin Fumery

Clin Gastroenterol Hepatol· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Subcutaneous Infliximab for Perianal Crohn's Disease: The BioLap-Rem Multicenter Study From the GETAID.
Marie André, Julien Kirchgesner, David Laharie, Lucas Guillo, Philippe Seksik, Mathurin Fumery

Am J Gastroenterol· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
International Magnetic Resonance Imaging Consensus for use in Luminal Crohn's Disease Trials and Clinical Practice.
Bénédicte Caron, Vipul Jairath, Bruce E Sands, David T Rubin, Mariangela Allocca, Mathurin Fumery

Clin Gastroenterol Hepatol· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of complete vs partial endoscopic healing on long-term outcomes in Crohn's disease: a prospective multicenter study.
Clara Yzet, Franck Brazier, Elise Derval, Pierre Vanelslander, Valérie Dejour, Mathurin Fumery

J Crohns Colitis· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparative effectiveness of tofacitinib versus upadacitinib for the treatment of acute severe ulcerative colitis.
Sailish Honap, Joelle St-Pierre, Michael Colwill, Kamal Patel, Catherine Le Berre, Mathurin Fumery

Clin Gastroenterol Hepatol· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparing standard versus intensified pneumococcal vaccination regimens in patients with inflammatory bowel disease on biologics: a prospective, multicenter, randomized, open-label study.
Xavier Roblin, Sophie Vieujean, Stéphane Nancey, Xavier Hebuterne, Nadia Arab-Hocine, Mathurin Fumery

J Crohns Colitis· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term disease course of ulcerative colitis in a prospective European population-based inception cohort-an Epi-IBD cohort study.
Mads Damsgaard Wewer, Søren Lophaven, Peter L Lakatos, Lorant Gonczi, Riina Salupere, Mathurin Fumery

J Crohns Colitis· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
J
Janus Kinase (JAK) Inhibitor-Induced Acne in Inflammatory Bowel Disease: An International, Multicenter, Retrospective Cohort Study.
Sailish Honap, Maria José Temido, Eathar Shakweh, Fakhirah Badrulhisham, Natalie Shields, Mathurin Fumery

Clin Gastroenterol Hepatol· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and Safety of Infliximab and Vedolizumab Maintenance Therapy in Patients with Crohn's Disease and Ulcerative Colitis: A Systematic Review and Meta-Analysis.
Bruce E Sands, Laurent Peyrin-Biroulet, Stefan Schreiber, Silvio Danese, Alessandro Armuzzi, Mathurin Fumery

J Clin Med· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis